Iglesias R, Llobera M, Montoya E
Horm Metab Res. 1986 Jul;18(7):454-6. doi: 10.1055/s-2007-1012344.
We have studied the thyrotropin (TSH) and thyroid hormone (T3) response to acute thyrotropin-releasing hormone (TRH) administration in rats previously rendered hyperthyroid by daily ip injection of 25 micrograms L-T4/100 g bw for 30 days. Animals were thereafter put on distilled water or TRH (2 mg/10 ml) as drinking solution for another 18 days, continuing T4 administration. On days 3 and 10 on oral TRH, the serum TSH and T3 response to TRH was studied by administering 2 micrograms of the tripeptide iv. After 3 days, neither the animals on oral DW, nor those on oral TRH showed any response. Nevertheless, after 10 days, animals on oral TRH had a measurable, significant thyrotropin response. At sacrifice (18 days), animals on oral TRH had increased pituitary TSH content. These results confirm and extend a recent report from our laboratory (Iglesias, Llobera and Montoya 1985). We conclude that TRH-mediated thyrotropin accumulation in pituitary is the primary cause for the presence of this response.
我们研究了促甲状腺激素(TSH)和甲状腺激素(T3)对急性促甲状腺激素释放激素(TRH)给药的反应,实验对象为大鼠,这些大鼠此前通过每天腹腔注射25微克L-T4/100克体重,连续注射30天,从而造成甲状腺功能亢进。此后,动物饮用蒸馏水或TRH(2毫克/10毫升)作为饮用水,持续18天,并继续给予T4。在口服TRH后的第3天和第10天,通过静脉注射2微克三肽来研究血清TSH和T3对TRH的反应。3天后,口服蒸馏水的动物和口服TRH的动物均未表现出任何反应。然而,10天后,口服TRH的动物出现了可测量的、显著的促甲状腺激素反应。在处死时(18天),口服TRH的动物垂体TSH含量增加。这些结果证实并扩展了我们实验室最近的一份报告(伊格莱西亚斯、洛贝拉和蒙托亚,1985年)。我们得出结论,TRH介导的垂体促甲状腺激素积累是这种反应存在的主要原因。